Role of sirtuin 6 in the protection of liver from the alcohol-induced injury
Role of sirtuin 6 in the protection of liver from the alcohol-induced injury
批准号:
9244917
负责人:
X Charlie Dong
金额:
$22.43万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-20 至 2019-03-31
关键词:
AddressAlcoholic Fatty LiverAlcoholic Liver DiseasesAlcoholic beverage heavy drinkerAlcoholic liver damageAlcoholsAnimal ModelAspartate TransaminaseBiochemicalCCL2 geneCell DeathCessation of lifeChIP-seqCharacteristicsCholesterolChronicCirrhosisDataDevelopmentDietDiseaseDrug TargetingEpigenetic ProcessEthanolExtracellular MatrixFatty LiverFibrosisFree Radical ScavengersGene ExpressionGene TargetingGenesGenetic studyGenomicsGluconeogenesisGlycolysisHealthHeavy DrinkingHepaticHepatocyteHistone DeacetylaseHomeostasisHumanHypoglycemiaInflammationInflammatoryInterleukin-1 betaInterleukin-6Knock-outKnockout MiceKnowledgeLifeLipidsLiverLiver CirrhosisLiver FibrosisLiver diseasesMetabolicMetabolismMetallothionein IMetallothionein IIMissionMolecularMonocyte Chemoattractant Protein-1MusOrganOxidative StressPathogenesisPathologyPathway interactionsPatientsPatternPhysiologicalPlayPreventionPrimary carcinoma of the liver cellsPrincipal InvestigatorPublic HealthRegulationReportingResearchRisk FactorsRoleSerumSirtuinsSkeletal MuscleSteatohepatitisTestingTherapeuticTissuesTransgenic MiceTriglyceridesUnited States National Institutes of Healthalcohol abuse therapyalcohol effectbiological adaptation to stressburden of illnessgenome-wideglucose uptakehuman diseaseliver injurymortalitymouse modelnew therapeutic targetnext generationnovelprematureproblem drinker
中文摘要
过量饮酒是酒精性肝病(ALD)的主要危险因素,
表现为一系列肝脏疾病,包括脂肪变性、脂肪性肝炎、纤维化、肝硬变、
甚至是肝细胞癌。酒精性肝硬变占总数的0.9%
2010年全球死亡人数和47.9%的肝硬变死亡人数。统计数字突出了
酒精对肝脏病理影响的意义。然而,潜在的机制
仍然难以捉摸,而且缺乏治疗方法。为了更好地理解分子
ALD的机制和识别潜在的药物靶点,这位首席研究员(PI)是
研究一种关键的表观遗传调控因子sirtuin 6(SIRT6),它是一种依赖NAD的组蛋白
脱乙酰酶,它与新陈代谢和炎症有关。SIRT6系统
基因敲除小鼠患有包括肝脏在内的多个器官的慢性炎症,并发展为
进行性肝纤维化。PI的初步研究表明,SIRT6基因的敲除
肝脏中的基因显著加重酒精诱导的肝损伤,使其水平升高
血清天冬氨酸氨基转移酶和纤维化标志物表达增加,提示
SIRT6参与了ALD的发生。我们假设SIRT6起到了防御酒精的作用-
导致肝脏损伤。为了检验这一假设,PI建议执行以下具体操作
目的:1)明确SIRT6在ALD发病中的作用;2)探索SIRT6在ALD发病中的新途径
对酒精性肝损伤的保护作用。总体而言,拟议的研究涉及
这是ALD领域的一个重要问题。人们期望对SIRT6在ALD中的作用有更好的理解
对这一严重疾病的防治工作的发展具有重要意义
疾病。
英文摘要
Excessive alcohol consumption is a major risk factor for alcoholic liver disease (ALD), which
manifests a spectrum of liver disorders including steatosis, steatohepatitis, fibrosis, cirrhosis,
and even hepatocellular carcinoma. Alcohol related liver cirrhosis accounted for 0.9% of all
global deaths and 47.9% of liver cirrhosis mortalities in 2010. The statistical numbers highlight
the significance of alcohol effects on the liver pathology. However, the underlying mechanisms
are still elusive and therapeutic treatments are lacking. To better understand the molecular
mechanisms of ALD and identify potential drug targets, this principal investigator (PI) is
investigating a critical epigenetic regulator, sirtuin 6 (Sirt6), an NAD-dependent histone
deacetylase, which has been implicated in metabolism and inflammation. Sirt6 systemic
knockout mice suffer chronic inflammation in multiple organs including the liver and develop
progressive hepatic fibrosis. The PI's preliminary study has revealed that knockout of the Sirt6
gene in the liver significantly worsens the alcohol-induced liver injury with elevated levels of
serum aspartate aminotransferase and increased expression of fibrosis markers, suggesting that
Sirt6 is involved in ALD. We hypothesize that Sirt6 functions as a safeguard against the alcohol-
induced liver damage. To test this hypothesis, the PI proposes to carry out the following specific
aims: 1) Define the role of Sirt6 in the development of ALD; 2) Explore a novel Sirt6 pathway in
the protection against the alcohol-induced liver injury. Overall, the proposed research addresses
an important problem in the ALD field. Better understanding of the role of Sirt6 in ALD is expected
to have significant implications for the development of prevention and treatment of this serious
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The pathophysiological function of PNPLA3-148M variant in alcohol-induced liver injury
-
批准号:10366395
-
项目类别:
-
资助金额:$46.02万
-
财政年份:2022
-
负责人:X Charlie Dong
-
依托单位:
Role of SIRT6 in the pancreatic beta cell aging
-
批准号:10371337
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2022
-
负责人:X Charlie Dong
-
依托单位:
Role of SIRT6 in the pancreatic beta cell aging
-
批准号:10641670
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2022
-
负责人:X Charlie Dong
-
依托单位:
The pathophysiological function of PNPLA3-148M variant in alcohol-induced liver injury
-
批准号:10613405
-
项目类别:
-
资助金额:$44.59万
-
财政年份:2022
-
负责人:X Charlie Dong
-
依托单位:
Role of ATG14 in the regulation of hepatic function
-
批准号:10596539
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Role of ATG14 in the regulation of hepatic function
-
批准号:10371047
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Epigenetic regulation in liver fibrosis
-
批准号:10640141
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Epigenetic regulation in liver fibrosis
-
批准号:10172893
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Epigenetic regulation in liver fibrosis
-
批准号:10428589
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease
-
批准号:9303199
-
项目类别:
-
资助金额:$34.91万
-
财政年份:2016
-
负责人:X Charlie Dong
-
依托单位:
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease
-
批准号:9188590
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2016
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:8234620
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:8617269
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:8448636
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:9018006
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:7685845
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:7769879
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:8001274
-
项目类别:
-
资助金额:$7.1万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:8019582
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:7320914
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2007
-
负责人:X Charlie Dong
-
依托单位:
海外基金